Melatonin Use in the Intensive Care Elderly Population

Status unconfirmed · Phase 4 · Has a placebo group

Conditions studied: Delirium, Melatonin

In brief

The investigators are studying the use of Melatonin in non-ventilated patients over the age of 65. Primary endpoint will be assesments of delirium, with secondary endpoints to include length of stay, use of anti-psychotic medications, and mortality

Key facts

Study ID

NCT03013790

Run by

MICE Trial Group

People needed

600

Starts

2016-12-01

Expected to finish

2018-01-01

Last updated by the study team

2017-07-13

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Non-ventilated Patients over the age of 65

You may not qualify if…

• Patients with head trauma or Neurosurgical intervention
• Patients <65 years of age
• Patients with an expected life expectancy <48 hours
• Blind patients
• Patients with a seizure history
• Patients with uncontrolled hypertension
• Patients with a supratheraputic (>3.0) INR
• Patients on strong CYP1A2 inhibitors: ciprofloxacin, fluvoxamine, methoxsalen, ofloxacin, primaquine
• Patients who do not speak English or Spanish

Where it is running

• Parkview Medical Center — Pueblo, Colorado, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.